Literature DB >> 1839374

Complement receptor type 1 (CR1, CD35) expression on peripheral T lymphocytes: both CD4- and CD8-positive cells express CR1.

A Rødgaard1, L D Christensen, B S Thomsen, A Wiik, G Bendixen.   

Abstract

T lymphocytes from 42 healthy blood donors were examined for expression of CR1 on the cell surface using a fluorescence-activated cell sorter. The fraction of CR1-positive T lymphocytes varied in the range from 1 to 8% (median 2.4%). The CR1-positive T lymphocytes constituted a homogeneous group of cells regarding both size and granulation; they seemed to be larger and more granulated than the average T lymphocytes. The CR1-expressing T lymphocytes were found both in the CD4- and in the CD8-positive subpopulations of T lymphocytes, and although the CD4-positive cells expressed CR1 with a slightly higher percentage than did the CD8-positive cells, this difference was not significant. The number of CR1-positive T lymphocytes did not correlate with the level of CR1 on erythrocytes. The presence of CR1 on a small T lymphocyte population suggests that CR1 on T lymphocytes might play a role in the immune regulation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1839374     DOI: 10.1159/000463200

Source DB:  PubMed          Journal:  Complement Inflamm        ISSN: 1012-8204


  8 in total

Review 1.  Complement involvement in kidney diseases: From physiopathology to therapeutical targeting.

Authors:  Maurizio Salvadori; Giuseppina Rosso; Elisabetta Bertoni
Journal:  World J Nephrol       Date:  2015-05-06

2.  Soluble CR1 therapy improves complement regulation in C3 glomerulopathy.

Authors:  Yuzhou Zhang; Carla M Nester; Danniele G Holanda; Henry C Marsh; Russell A Hammond; Lawrence J Thomas; Nicole C Meyer; Lawrence G Hunsicker; Sanjeev Sethi; Richard J H Smith
Journal:  J Am Soc Nephrol       Date:  2013-08-01       Impact factor: 10.121

3.  Increased expression of complement receptor type 1 (CR1, CD35) on human peripheral blood T lymphocytes after polyclonal activation in vitro.

Authors:  A Rodgaard; B S Thomsen; G Bendixen; K Bendtzen
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

4.  A novel mouse model expressing human forms for complement receptors CR1 and CR2.

Authors:  Harriet M Jackson; Kate E Foley; Rita O'Rourke; Timothy M Stearns; Dina Fathalla; B Paul Morgan; Gareth R Howell
Journal:  BMC Genet       Date:  2020-09-09       Impact factor: 2.797

Review 5.  Complement Receptors and Their Role in Leukocyte Recruitment and Phagocytosis.

Authors:  Sofie Vandendriessche; Seppe Cambier; Paul Proost; Pedro E Marques
Journal:  Front Cell Dev Biol       Date:  2021-02-11

6.  Synthetic immunotherapy induces HIV virus specific Th1 cytotoxic response and death of an HIV-1 infected human cell line through classic complement activation.

Authors:  Olga Pleguezuelos; Gregory A Stoloff; Wilson Caparrós-Wanderley
Journal:  Virol J       Date:  2013-04-04       Impact factor: 4.099

Review 7.  Viral Evasion of the Complement System and Its Importance for Vaccines and Therapeutics.

Authors:  Jack Mellors; Tom Tipton; Stephanie Longet; Miles Carroll
Journal:  Front Immunol       Date:  2020-07-09       Impact factor: 7.561

Review 8.  Complement Receptor 1: disease associations and therapeutic implications.

Authors:  Rohan Khera; Nibhriti Das
Journal:  Mol Immunol       Date:  2008-11-11       Impact factor: 4.407

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.